Fidaxomicin
DIFICID
Macrolide Antibacterial
NADAC/unit
$193.6654
No Shortage
Tier 1: 38.0%
PA Req: 38.9%
3 Manufacturers
3 ANDAs
vs. brand DIFICID: Generic saves up to -1837% per unit
Generic Manufacturers
ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCAPOTEX INCCUBIST PHARMACEUTICALS LLCTORRENT PHARMACEUTICALS LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
